Evidence map›Paper›PMID 30735627›Full record

ArticleThe American journal of pathology2019

Macrophage-Mediated Phagocytosis and Dissolution of Amyloid-Like Fibrils in Mice, Monitored by Optical Imaging.

Tina Richey, James S Foster, Angela D Williams, Anna B Williams, Alexa Stroh, Sallie Macy, Craig Wooliver, R Eric Heidel, Siva K Varanasi, Elizabeth N Ergen and 5 more

Open access · bronzeAbstract read
In one paragraph

Article in The American journal of pathology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
0.6field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 2 institutions in 1 country.

Tina RicheyDepartment of Medicine, University of Tennessee Medical Center, Knoxville, Tennessee.
James S FosterDepartment of Medicine, University of Tennessee Medical Center, Knoxville, Tennessee.
Angela D WilliamsDepartment of Medicine, University of Tennessee Medical Center, Knoxville, Tennessee.
Anna B WilliamsWebb School of Knoxville, Knoxville, Tennessee.
Alexa StrohDepartment of Biochemistry, Cellular and Molecular Biology, College of Veterinary Medicine, University of Tennessee, Knoxville, Tennessee.
Sallie MacyDepartment of Medicine, University of Tennessee Medical Center, Knoxville, Tennessee.
Craig WooliverDepartment of Medicine, University of Tennessee Medical Center, Knoxville, Tennessee.
R Eric HeidelDepartment of Surgery, University of Tennessee Medical Center, Knoxville, Tennessee.
Siva K VaranasiDepartment of Biochemistry, Cellular and Molecular Biology, College of Veterinary Medicine, University of Tennessee, Knoxville, Tennessee.
Elizabeth N ErgenDepartment of Medicine, University of Tennessee Medical Center, Knoxville, Tennessee.
Dianne J TrentDepartment of Biomedical and Diagnostic Sciences, College of Veterinary Medicine, University of Tennessee, Knoxville, Tennessee.
Stephen A KaniaDepartment of Biomedical and Diagnostic Sciences, College of Veterinary Medicine, University of Tennessee, Knoxville, Tennessee.
Stephen J KennelDepartment of Medicine, University of Tennessee Medical Center, Knoxville, Tennessee.
Emily B MartinDepartment of Medicine, University of Tennessee Medical Center, Knoxville, Tennessee.
Jonathan S WallDepartment of Medicine, University of Tennessee Medical Center, Knoxville, Tennessee. Electronic address: jwall@utmck.edu.
University of Tennessee Medical Center · USUniversity of Tennessee at Knoxville · US

Funding

Pre-targeting immunotherapy for light chain (AL) amyloidosisR01DK110038 · NIDDK · UNIVERSITY OF TENNESSEE HEALTH SCI CTR · PI WALL, JONATHAN S · 2017 to 2019
$1.1M
NIDDK NIH HHS R01 DK110038
6 · The paper itself

Abstract

Light chain-associated amyloidosis is characterized by the extracellular deposition of amyloid fibrils in abdominothoracic organs, skin, soft tissue, and peripheral nerves. Phagocytic cells of the innate immune system appear to be ineffective at clearing the material; however, human light chain amyloid extract, injected subcutaneously into mice, is rapidly cleared in a process that requires neutrophil activity. To better elucidate the phagocytosis of light chain fibrils, a potential method of cell-mediated dissolution, amyloid-like fibrils were labeled with the pH-sensitive dye pHrodo red and a near infrared fluorophore. After injecting this material subcutaneously in mice, optical imaging was used to quantitatively monitor phagocytosis and dissolution of fibrils concurrently. Histologic evaluation of the residual fibril masses revealed the presence of CD68

Indexed as

PhagocytosisAmyloidAmyloidosisAnimalsFemaleMacrophagesMiceOptical ImagingAmyloid

Identifiers

PMID30735627
PMCPMC6521888
OpenAlexW2913944996

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.